Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

2.6K
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Research of the effect of para-tumoral micro-metastasis on the outcome after radical resection for intrahepatic cholangiocarcinoma].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

Dietary supplementation of proteases on growth performance, nutrient digestibility, blood characteristics and gut microbiota of growing pigs fed sorghum-based diets.

Animal : an international journal of animal bioscience·2024
Same author

Active screening and patient-placement and cohort-placement strategies to decrease carbapenem-resistant gram-negative bacilli colonization and infection in pediatric patients: A 5-year retrospective observational study in China.

Infection control and hospital epidemiology·2023
Same author

[Management strategy and practice for SARS-CoV-2 infection in children's hospital].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2022
Same author

[Management and short-term outcomes of neonates born to mothers infected with SARS-CoV-2 Omicron variant].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2022
Same author

[Pathological diagnosis of rare and salivary gland-type tumors of breast].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2022
Same journal

Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.

Leukemia·2026
Same journal

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

Leukemia·2026
Same journal

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

Leukemia·2026
Same journal

Linperlisib enhances MUC1-Tn CAR T cell efficacy by inhibiting EGR1/DUSP2 axis to prevent CAR T cell exhaustion.

Leukemia·2026
Same journal

CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia.

Leukemia·2026
Same journal

Single-cell architecture of purinergic signaling in human cord blood hematopoietic stem and progenitor cells.

Leukemia·2026
See all related articles

Related Experiment Video

Updated: Apr 7, 2026

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

21.6K

Mouse models for core binding factor leukemia.

D W L Chin1, N Watanabe-Okochi1, C Q Wang1,2

  • 1Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

Leukemia
|July 14, 2015
PubMed
Summary
This summary is machine-generated.

Core binding factor (CBF) leukemias involve RUNX1 and CBF mutations. Current mouse models have limitations, necessitating improved models for effective drug discovery and better leukemia survival rates.

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

849
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.9K

Related Experiment Videos

Last Updated: Apr 7, 2026

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

21.6K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

849
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.9K

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • RUNX1 and CBF genes are frequently mutated in human leukemias, leading to core binding factor (CBF) leukemias.
  • CBF leukemias, despite favorable risk classification, have low 5-year survival rates, highlighting the need for better understanding and treatment.
  • RUNX gene alterations are critical in leukemogenesis, necessitating detailed study of their molecular mechanisms.

Purpose of the Study:

  • To review existing mouse models for studying core binding factor (CBF) leukemias.
  • To discuss the advantages and limitations of current experimental systems for CBF leukemia research.
  • To propose improvements for mouse models to facilitate drug discovery and enhance leukemia treatment.

Main Methods:

  • Review of retroviral transduction-transplantation assays.
  • Analysis of transgenic, knockin, and knockout mouse models.
  • Evaluation of mutagenesis in combination with mouse models for leukemogenesis studies.

Main Results:

  • Existing mouse models and assays have limitations in inducing leukemia with complete penetrance and short latency.
  • Current experimental systems have inherent drawbacks for comprehensive study of CBF leukemias.
  • There is a clear need for optimized mouse models for drug discovery in CBF leukemia.

Conclusions:

  • Improved mouse models are essential for advancing the understanding of CBF leukemia.
  • Optimized models with complete penetrance and short latency are crucial for drug discovery platforms.
  • Further development of experimental systems will aid in uncovering novel therapeutic strategies for CBF leukemia.